217 related articles for article (PubMed ID: 27561800)
1. [Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer
with Brain Metastases].
Qu L; Geng R; Song X
Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):515-8. PubMed ID: 27561800
[TBL] [Abstract][Full Text] [Related]
2. [Research progress of targeted therapy in non-small cell lung cancer brain metastases].
Jiang T; Zhou C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):824-8. PubMed ID: 25404274
[TBL] [Abstract][Full Text] [Related]
3. Targeting angiogenesis for treatment of NSCLC brain metastases.
Schettino C; Bareschino MA; Rossi A; Maione P; Sacco PC; Colantuoni G; Rossi E; Gridelli C
Curr Cancer Drug Targets; 2012 Mar; 12(3):289-99. PubMed ID: 22229249
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study.
Besse B; Le Moulec S; Mazières J; Senellart H; Barlesi F; Chouaid C; Dansin E; Bérard H; Falchero L; Gervais R; Robinet G; Ruppert AM; Schott R; Léna H; Clément-Duchêne C; Quantin X; Souquet PJ; Trédaniel J; Moro-Sibilot D; Pérol M; Madroszyk AC; Soria JC
Clin Cancer Res; 2015 Apr; 21(8):1896-903. PubMed ID: 25614446
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab Plus Radiosurgery for Nonsquamous Non-Small Cell Lung Cancer Patients with Brain Metastases: Safe Combination?
Guinde J; Carron R; Tomasini P; Greillier L; Régis J; Barlesi F
World Neurosurg; 2017 Nov; 107():1047.e1-1047.e4. PubMed ID: 28803179
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases.
Ascha MS; Wang JF; Kumthekar P; Sloan AE; Kruchko C; Barnholtz-Sloan JS
Sci Rep; 2019 Nov; 9(1):17792. PubMed ID: 31780762
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience.
Greillier L; Tomasini P; Barlesi F
Ther Adv Respir Dis; 2016 Oct; 10(5):485-91. PubMed ID: 27340254
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab in Combination with Platinum-Based Chemotherapy in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with or without Brain Metastases: A French Cohort Study (EOLE).
Bennouna J; Falchero L; Schott R; Bonnetain F; Coudert M; Ben Hadj Yahia B; Chouaid C
Oncology; 2018; 94(1):55-64. PubMed ID: 29065416
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer.
De Braganca KC; Janjigian YY; Azzoli CG; Kris MG; Pietanza MC; Nolan CP; Omuro AM; Holodny AI; Lassman AB
J Neurooncol; 2010 Dec; 100(3):443-7. PubMed ID: 20440540
[TBL] [Abstract][Full Text] [Related]
10. Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases.
Wang Z; Yang JJ; Tu HY; Yan HH; Wu YL
Int J Clin Oncol; 2020 Feb; 25(2):267-273. PubMed ID: 31587134
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer.
Yang RF; Yu B; Zhang RQ; Wang XH; Li C; Wang P; Zhang Y; Han B; Gao XX; Zhang L; Jiang ZM
Braz J Med Biol Res; 2017 Nov; 51(1):e6073. PubMed ID: 29185589
[TBL] [Abstract][Full Text] [Related]
12. Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases.
Socinski MA; Langer CJ; Huang JE; Kolb MM; Compton P; Wang L; Akerley W
J Clin Oncol; 2009 Nov; 27(31):5255-61. PubMed ID: 19738122
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model.
Masuda C; Sugimoto M; Wakita D; Monnai M; Ishimaru C; Nakamura R; Kinoshita M; Yorozu K; Kurasawa M; Kondoh O; Yamamoto K
Clin Exp Metastasis; 2020 Feb; 37(1):199-207. PubMed ID: 31768815
[TBL] [Abstract][Full Text] [Related]
14. Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer.
Bowden G; Kano H; Caparosa E; Park SH; Niranjan A; Flickinger J; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):766-72. PubMed ID: 25658792
[TBL] [Abstract][Full Text] [Related]
15. Ongoing trials with bevacizumab and other antiangiogenic agents in lung cancer.
Dowlati A
Clin Lung Cancer; 2008 Mar; 9 Suppl 2():S71-5. PubMed ID: 21885002
[TBL] [Abstract][Full Text] [Related]
16. Brain Metastases in NSCLC - are TKIs Changing the Treatment Strategy?
Dempke WC; Edvardsen K; Lu S; Reinmuth N; Reck M; Inoue A
Anticancer Res; 2015 Nov; 35(11):5797-806. PubMed ID: 26504000
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma.
Ilhan-Mutlu A; Osswald M; Liao Y; Gömmel M; Reck M; Miles D; Mariani P; Gianni L; Lutiger B; Nendel V; Srock S; Perez-Moreno P; Thorsen F; von Baumgarten L; Preusser M; Wick W; Winkler F
Mol Cancer Ther; 2016 Apr; 15(4):702-10. PubMed ID: 26809491
[TBL] [Abstract][Full Text] [Related]
18. [Multimodal Treatment of Non-Small Cell Lung Cancer with Cerebral Metastases].
Kudelin N; Bölükbas S; Schirren J
Zentralbl Chir; 2015 Jun; 140(3):328-33. PubMed ID: 26114639
[TBL] [Abstract][Full Text] [Related]
19. [Management of brain metastases from non-small cell lung carcinoma].
Bailon O; Kallel A; Chouahnia K; Billot S; Ferrari D; Carpentier AF
Rev Neurol (Paris); 2011; 167(8-9):579-91. PubMed ID: 21546046
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab-Based Therapy for Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Preliminary Results.
Zustovich F; Ferro A; Lombardi G; Farina P; Zagonel V
Chemotherapy; 2014; 60(5-6):294-9. PubMed ID: 25999127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
